Founding executive director and chief science officer, Alzheimer's Drug Discovery Foundation
Updates on the Diagnostics Accelerator, Future Goals of the ADDF: Howard Fillit, MDFebruary 1st 2022
The founding executive director of the Alzheimer’s Drug Discovery Foundation commented on ongoing developments from the organization, particularly the diagnostics accelerator, which aims at identifying a better way to diagnose Alzheimer disease. [WATCH TIME: 6 minutes]
The Development of Technology for Alzheimer Disease: Howard Fillit, MDJanuary 31st 2022
Discussing recent technological advancements in the AD field, the founding executive director of the Alzheimer’s Drug Discovery Foundation noted the doors that these innovations have opened. [WATCH TIME: 4 minutes]
Howard Fillit, MD: Telemedicine and Tech in the Future Care of Alzheimer and DementiaMay 6th 2020
The founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation detailed what he foresees the future of Alzheimer and dementia care to look like with telemedicine as a more permanent aspect of care.
Howard Fillit, MD: The Positives of Telemedicine Adoption for Geriatric PatientsMay 2nd 2020
The founding executive director and chief science officer at the Alzheimer’s Drug Discovery Foundation spoke to the way the COVID-19 pandemic has transformed the use of telemedicine for the elderly with conditions like Alzheimer and dementia.